🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for PROC

A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency NCT06590974n/a1 site📍 Tokyo Takeda · Tests: Freeze-dried Human Protein C Concentrate C-Protein in Fatigue and Aging NCT05926219NA1 site📍 Eugene University of Oregon · Tests: Fatiguing Exercise A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine NCT03854110Phase 14 sites📍 Chicago📍 Fairway📍 Boston Persevere Therapeutics Inc. · Tests: misetionamide (also known as GP-2250) A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors NCT05914116Phase 1, Phase 2107 sites📍 Tucson📍 Los Angeles📍 Los Angeles DualityBio Inc. · Tests: DB-1311, Lopinavir and Ritonavir Tablets, itraconazole, Enzalutamide, Abiraterone Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer. NCT07755436Phase 16 sites📍 Orlando📍 Boston📍 Nashville ArriVent BioPharma, Inc. · Tests: ARR-002 A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. NCT07470853Phase 112 sites📍 Little Rock📍 Los Angeles📍 Sarasota Whitehawk Therapeutics, Inc. · Tests: HWK-016, MUCIN-16-targeted ADC, Bevacizumab Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites📍 Phoenix📍 Tucson📍 Los Angeles Genmab · Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors NCT07444814Phase 112 sites📍 Little Rock📍 Los Angeles📍 Peoria Whitehawk Therapeutics, Inc. · Tests: HWK-007 An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China NCT07604766Phase 317 sites📍 Changchun📍 Changsha📍 Chengdu Genmab · Tests: Rina-S, Paclitaxel, Topotecan, Pegylated liposomal doxorubicin (PLD), Gemcitabine FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC NCT06303505Phase 1, Phase 229 sites📍 Birmingham📍 New Haven📍 Atlanta Gilead Sciences · Tests: TUB-040 Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM NCT05836259Phase 1, Phase 210 sites📍 La Jolla📍 San Francisco📍 Atlanta Tenaya Therapeutics · Tests: TN-201 SMP-3124LP in Adults With Advanced Solid Tumors NCT06526819Phase 1, Phase 213 sites📍 Los Angeles📍 San Francisco📍 Denver Sumitomo Pharma America, Inc. · Tests: SMP3124LP A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression NCT07546500Phase 359 sites📍 Phoenix📍 Antioch📍 Beverly Hills K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis … · Tests: Investigator's choice of Chemotherapy, Azenosertib A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) NCT05824975Phase 1, Phase 211 sites📍 Scottsdale📍 Jacksonville📍 Rochester GI Innovation, Inc. · Tests: GI-102 subcutaneous (SC), GI-102, doxorubicin, paclitaxel, bevacizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy